Sacubitril and Valsartan-Test product

DRUG2 trials

Sponsors

Bio-innova Co., Ltd, Humanis Saglık Anonim Sirketi

Conditions

Chronic Heart FailureHealthy Subjects

Phase 1

Sacubitril 97 mg and Valsartan 103 mg Film-coated Tablets Relative to Entresto 97 mg/103 mg Film-coated Tablets

Not yet recruitingNCT06248112

Bio-innova Co., LtdHealthy Subjects

Start: 2024-05-06End: 2024-07-06Target: 40Updated: 2024-02-08

Bioequivalence Study to Compare Sacubitril and Valsartan Tablets (97mg/103mg) Versus Entresto® (Sacubitril and Valsartan) Tablets (97 mg/103 mg)

CompletedNCT06922253

Humanis Saglık Anonim SirketiChronic Heart Failure

Start: 2024-12-28End: 2025-03-17Updated: 2025-04-10